Literature DB >> 7500913

Detection of specific human immunodeficiency virus IgM antibodies.

H Hampl1, H P Kapprell, D Sawitzky, W Wilske, L Gürtler.   

Abstract

This study was done to demonstrate whether the use of the antigen-sandwich human immunodeficiency virus (HIV) antibody-screening assays (3rd generation assays), which detect all classes of anti-HIV immunoglobulins, leads to an earlier detection of HIV IgM compared to the 2nd generation HIV antibody-screening assays. We tested sequential bleeds of three donors obtained from commercially available seroconversion panels. Anti-HIV testing was done before and after high-performance liquid chromatography separation of IgG and IgM fractions. The positive result of the first bleedings from all three panels was linked to the IgM fraction, while at that time the IgG fraction was still negative. For subsequent samples drawn 5-9 days later, a positive signal was obtained with the IgG fraction in addition to a stronger positive signal obtained with the IgM fraction. We conclude that an assay capable of simultaneously detecting different immunoglobulin classes, including IgM, will help to narrow the "window period" for serological detection of seroconversion to HIV by detecting anti-HIV IgM-containing samples earlier than conventional assays using only anti-human IgG enzyme conjugates (indirect anti-HIV-screening assay, 2nd generation assays).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7500913     DOI: 10.1007/bf00221389

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  5 in total

1.  HIV viraemia and seroconversion.

Authors:  W Lu; D Eme; J M Andrieu
Journal:  Lancet       Date:  1993-01-09       Impact factor: 79.321

2.  Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type 1. The Transfusion Safety Study Group.

Authors:  M P Busch; P E Taylor; B A Lenes; S H Kleinman; M Stuart; C E Stevens; P A Tomasulo; J P Allain; C G Hollingsworth; J W Mosley
Journal:  N Engl J Med       Date:  1990-11-08       Impact factor: 91.245

3.  Multicenter evaluation of a new recombinant enzyme immunoassay for the combined detection of antibody to HIV-1 and HIV-2.

Authors:  L Ayres; F Avillez; A Garcia-Benito; F Deinhardt; L Gürtler; F Denis; G Léonard; S Ranger; P Grob; H Joller-Jemelka
Journal:  AIDS       Date:  1990-02       Impact factor: 4.177

4.  Early detection of antibody to human immunodeficiency virus type 1 by using an antigen conjugate immunoassay correlates with the presence of immunoglobulin M antibody.

Authors:  J L Gallarda; D R Henrard; D Liu; S Harrington; S L Stramer; J E Valinsky; P Wu
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

5.  Sensitivity of HIV-antibody assays determined by seroconversion panels.

Authors:  N T Constantine; G van der Groen; E M Belsey; H Tamashiro
Journal:  AIDS       Date:  1994-12       Impact factor: 4.177

  5 in total
  1 in total

1.  Distinguishing Incubation and Acute Disease Stages of Mild-to-Moderate COVID-19.

Authors:  Michael Müller; Johann Volzke; Behnam Subin; Christian Johann Schmidt; Hilte Geerdes-Fenge; Emil Christian Reisinger; Brigitte Müller-Hilke
Journal:  Viruses       Date:  2022-01-20       Impact factor: 5.048

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.